117 related articles for article (PubMed ID: 18471046)
1. Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.
Clarke JW; Chang EL; Levin VA; Mayr NA; Hong E; Cavaliere R; Lo SS
Expert Rev Anticancer Ther; 2008 May; 8(5):733-41. PubMed ID: 18471046
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
[TBL] [Abstract][Full Text] [Related]
3. Short course of radiation therapy in elderly patients with glioblastoma multiforme.
Idbaih A; Taillibert S; Simon JM; Psimaras D; Schneble HM; Lopez S; Lang P; Toubiana T; Feuvret L; Delattre JY; Mazeron JJ
Cancer Radiother; 2008 Dec; 12(8):788-92. PubMed ID: 19046921
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of prognostic factors in patients with glioblastoma.
Lutterbach J; Sauerbrei W; Guttenberger R
Strahlenther Onkol; 2003 Jan; 179(1):8-15. PubMed ID: 12540979
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
[TBL] [Abstract][Full Text] [Related]
8. Postoperative hypofractionated radiotherapy in glioblastoma multiforme.
Arslan M; Karadeniz AN; Aksu G; Güveli M; Fayda M; Doğan AK; Akyüz F
J BUON; 2006; 11(1):39-42. PubMed ID: 17318950
[TBL] [Abstract][Full Text] [Related]
9. Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme.
Fuller CD; Choi M; Forthuber B; Wang SJ; Rajagiriyil N; Salter BJ; Fuss M
Radiat Oncol; 2007 Jul; 2():26. PubMed ID: 17629934
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
[TBL] [Abstract][Full Text] [Related]
11. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
Singh D; Banerji AK; Dwarakanath BS; Tripathi RP; Gupta JP; Mathew TL; Ravindranath T; Jain V
Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
13. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
[TBL] [Abstract][Full Text] [Related]
14. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
[TBL] [Abstract][Full Text] [Related]
15. [Results of conventional radiotherapy in malignant gliomas:].
Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M
Gan No Rinsho; 1989 Sep; 35(11):1240-6. PubMed ID: 2554004
[TBL] [Abstract][Full Text] [Related]
16. Treatment of elderly patients with glioblastoma: from clinical evidence to molecular highlights.
Chargari C; Feuvret L; Bauduceau O; Ricard D; Cuenca X; Delattre JY; Mazeron JJ
Cancer Treat Rev; 2012 Dec; 38(8):988-95. PubMed ID: 22289687
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
[TBL] [Abstract][Full Text] [Related]
18. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma in children: a single-institution experience.
Perkins SM; Rubin JB; Leonard JR; Smyth MD; El Naqa I; Michalski JM; Simpson JR; Limbrick DL; Park TS; Mansur DB
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1117-21. PubMed ID: 21220190
[TBL] [Abstract][Full Text] [Related]
20. Evolution of care for patients with relapsed glioblastoma.
Balañá C; Villá S; Teixidor P
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1719-29. PubMed ID: 22050021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
